11/25/2020
5:02 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
5:00 PM | AFEYAN NOUBAR (Reporting)
Flagship Pioneering Fund VI General Partner LLC (Reporting)
Flagship Pioneering Fund VI, L.P. (Reporting)
Flagship Pioneering Inc. (Reporting)
Flagship Ventures Fund IV General Partner LLC (Reporting)
Flagship Ventures Fund IV, L.P. (Reporting)
Flagship Ventures Fund IV-Rx, L.P. (Reporting)
Nutritional Health LTP Fund General Partner LLC (Reporting)
Nutritional Health LTP Fund, L.P. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2020
3:30 PM | Flagship VentureLabs IV, LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13D/A
| |
11/20/2020
6:30 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2020
8:53 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/21/2020
4:02 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/21/2020
4:00 PM | Ege David S. (Reporting)
Seres Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/09/2020
1:17 PM | ARK Investment Management LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A
| |
09/10/2020
9:03 AM | FMR LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A
| |
09/09/2020
5:03 AM | Seres Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G/A
| |
|
09/08/2020
12:28 PM | Nikko Asset Management Americas, Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A
| |
08/19/2020
4:17 PM | Nestle Health Science US Holdings, Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13D/A
| |
08/17/2020
3:21 PM | Seres Therapeutics (Subject)
| Form FWP
| |
08/14/2020
4:08 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2020
4:05 PM | Seres Therapeutics (Filer)
| Form 424B5
| |
08/14/2020
4:03 PM | Seres Therapeutics (Filer)
| Form 424B5
| |
08/13/2020
5:05 AM | Seres Therapeutics (Subject)
| Form FWP
| |
08/11/2020
4:30 PM | Seres Therapeutics (Filer)
| Form 424B5
| |
08/11/2020
4:11 PM | Seres Therapeutics (Filer)
| Form S-3ASR
| |
08/10/2020
6:31 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/28/2020
9:01 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/01/2020
3:07 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/01/2020
3:05 PM | Seres Therapeutics (Issuer)
Young Teresa L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/22/2020
3:18 PM | Biondi Paul (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2020
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/07/2020
3:18 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/07/2020
3:16 PM | Seres Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/23/2020
6:16 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2020
11:15 PM | Seres Therapeutics (Filer)
| Form EFFECT
| |
03/18/2020
3:43 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2020
3:39 PM | Seres Therapeutics (Filer)
| Form 424B5
| |
03/09/2020
3:18 PM | Seres Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/02/2020
6:13 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2020
4:24 PM | Nikko Asset Management Americas, Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A
| |
02/12/2020
5:02 AM | Seres Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G/A
| |
02/07/2020
7:45 AM | BlackRock Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G
| |
01/28/2020
3:07 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:06 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:05 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2020
3:05 PM | Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2019
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2019
7:40 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2019
7:38 AM | Seres Therapeutics (Filer)
| Form 424B5
| |
11/25/2019
3:32 PM | Chapman Marcus (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2019
11:11 AM | FMR LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G/A
| |
11/05/2019
1:12 PM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2019
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2019
4:01 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2019
5:19 AM | Seres Therapeutics (Subject)
Sumitomo Mitsui Trust Holdings, Inc. (Filed by)
| Form SC 13G
| |
09/06/2019
1:17 PM | Nikko Asset Management Americas, Inc. (Filed by)
Seres Therapeutics (Subject)
| Form SC 13G
| |
08/06/2019
6:51 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2019
6:49 PM | Berenson Stephen (Reporting)
Seres Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/06/2019
10:18 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/06/2019
6:04 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2019
6:01 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2019
3:25 PM | Seres Therapeutics (Subject)
| Form SC 13G/A
| |
06/28/2019
3:30 PM | Flagship VentureLabs IV, LLC (Filed by)
Seres Therapeutics (Subject)
| Form SC 13D
| |
06/28/2019
3:30 PM | Flagship Pioneering Fund VI General Partner LLC (Reporting)
Flagship Pioneering Fund VI, L.P. (Reporting)
Flagship Pioneering Inc. (Reporting)
Nutritional Health LTP Fund General Partner LLC (Reporting)
Nutritional Health LTP Fund, L.P. (Reporting)
Seres Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2019
3:17 PM | AFEYAN NOUBAR (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:19 PM | Kim Lorence H. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:19 PM | Pomerantz Roger (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:16 PM | AFEYAN NOUBAR (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2019
3:06 PM | Seres Therapeutics (Filer)
| Form 424B5
| |
06/12/2019
4:13 PM | Seres Therapeutics (Filer)
| Form 424B5
| |
05/02/2019
8:52 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/02/2019
6:03 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
3:14 PM | Seres Therapeutics (Filer)
| Form DEFA14A
| |
04/30/2019
3:10 PM | Seres Therapeutics (Filer)
| Form DEF 14A
| |
04/24/2019
3:15 PM | Chapman Marcus (Reporting)
Seres Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/18/2019
3:05 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2019
2:42 PM | Seres Therapeutics (Filer)
| Form CT ORDER
| |
03/11/2019
9:02 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2019
12:11 PM | Seres Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2019
10:19 AM | Seres Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2019
6:00 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2019
6:18 PM | Henn Matthew R. (Reporting)
Seres Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2019
5:55 PM | HORGAN KEVIN (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
5:55 PM | DesRosier Thomas (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
5:52 PM | Seres Therapeutics (Issuer)
Shaff Eric D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
5:51 PM | Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
5:51 PM | COOK DAVID N (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/15/2019
6:10 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2018
3:11 PM | Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2018
7:50 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2018
3:27 PM | Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2018
9:11 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2018
6:05 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2018
3:13 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2018
4:58 PM | HORGAN KEVIN (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2018
4:57 PM | HORGAN KEVIN (Reporting)
Seres Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/22/2018
6:03 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2018
3:16 PM | Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2018
8:22 PM | Aunins John G. (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2018
3:49 PM | Pomerantz Roger (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2018
4:08 PM | Pomerantz Roger (Reporting)
Seres Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2018
3:49 PM | Seres Therapeutics (Issuer)
Zausner Meryl (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2018
3:43 PM | Seres Therapeutics (Issuer)
Zausner Meryl (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/04/2018
6:49 AM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2018
12:06 PM | Seres Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2018
10:37 AM | Seres Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
